AnGes. Inc.
AnGes, Inc. develops gene‑based therapeutics—HGF plasmid for chronic arterial occlusion, NF‑kB decoy oligonucleotide for discogenic back pain, and DNA vaccines for hypertension—positioning itself as a diversified life‑science biotech with global partnership potential.
Headquarters: Japan (JPN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical and Diagnostic Laboratories
- Employees: 55
- HQ: Ibaraki
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.